PTPRC and renal fibrosis: The beneficial effects of FXIIa inhibition in the UUO model were dependent neither on CD45+ or F4/80 macrophage numbers, otherwise known to play a prominent role in renal fibrosis [48], nor inflammation, even though anti-inflammatory effects of 3F7 have been reported [49].